Avanos Medical Return On Assets Over Time

AVNS Stock  USD 19.16  0.02  0.10%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Avanos Medical Performance and Avanos Medical Correlation.
For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.
  
Return On Assets is likely to gain to -0.03 in 2024.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avanos Medical. If investors know Avanos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avanos Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.38)
Earnings Share
0.47
Revenue Per Share
14.791
Quarterly Revenue Growth
(0.01)
Return On Assets
0.0208
The market value of Avanos Medical is measured differently than its book value, which is the value of Avanos that is recorded on the company's balance sheet. Investors also form their own opinion of Avanos Medical's value that differs from its market value or its book value, called intrinsic value, which is Avanos Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avanos Medical's market value can be influenced by many factors that don't directly affect Avanos Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avanos Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avanos Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avanos Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Return On Assets Analysis

Compare Avanos Medical and related stocks such as Artivion, Anika Therapeutics, and Sight Sciences Return On Assets Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
AORT(0.0642)0.04980.05060.09260.04160.02210.03410.0063(0.0067)0.0028(0.0211)(0.0187)(0.0252)(0.0387)(0.0368)
ANIK(0.1667)0.06370.08280.13190.19750.13050.13550.11260.06710.0822(0.0656)0.0119(0.0426)(0.3055)(0.29)
SGHT(1.7655)(1.7655)(1.7655)(1.7655)(1.7655)(1.7655)(1.7655)(1.7655)(1.7655)(0.8415)(0.4765)(0.2247)(0.4048)(0.3333)(0.35)
OFIX0.1699(0.0015)0.1017(0.0667)(0.0217)(0.007)0.00820.01540.0296(0.0574)0.0048(0.0805)(0.0431)(0.1636)(0.16)
AXGN0.0746(0.7378)(0.4655)(0.5258)(1.0799)(0.3557)(0.3108)(0.1774)(0.1398)(0.1883)(0.1232)(0.1349)(0.1399)(0.1103)(0.12)
SRDX0.06580.09850.14880.11470.13420.07510.0287(0.0272)0.04750.00670.0218(0.1722)(0.0083)(0.0646)(0.0614)
FNA0.04180.04180.04180.04180.04180.04180.04180.04180.04180.04180.0275(0.0584)(0.2649)(0.1404)(0.15)
GKOS(3.7427)(3.7427)(3.7427)(0.4093)(0.466)(0.3192)0.0337(6.0E-4)(0.0626)0.0188(0.1197)(0.0472)(0.099)(0.1432)(0.15)
KIDS(0.2665)(0.2665)(0.2665)(0.2665)(0.2665)(0.2571)(0.2142)(0.1085)(0.1073)(0.0884)(0.1028)(0.0534)0.0029(0.0478)(0.0502)
CNMD0.0878.0E-40.03730.0330.02930.02740.0110.04090.02980.01610.00540.0354(0.0351)0.0280.0422
LIVN(0.4061)0.17030.17560.18660.18660.0226(0.0268)(0.01)(0.0743)(0.0645)(0.1424)(0.0617)(0.0376)0.00720.0076
ITGR(0.0108)(0.0025)(0.0025)(0.0025)(0.0025)(0.0025)0.07220.07220.04090.04090.03260.03750.02380.03080.0213
TMCI(0.1718)(0.1718)(0.1718)(0.1718)(0.1718)(0.1718)(0.1718)(0.1718)(0.1718)(0.1718)(0.1542)(0.1748)(0.2974)(0.1966)(0.21)
ESTA(0.7496)(0.7496)(0.7496)(0.7496)(0.7496)(0.7496)(0.7496)(0.6112)(0.181)(0.3274)(0.2438)(0.2948)(0.3563)(0.2922)(0.31)
NVRO(0.3862)(0.3862)(0.3862)(0.345)(0.1515)(0.2316)(0.0738)(0.0807)(0.1062)(0.2208)(0.1052)(0.2286)0.005(0.1451)(0.15)

Avanos Medical and related stocks such as Artivion, Anika Therapeutics, and Sight Sciences Return On Assets description

A profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets.

My Equities

My Current Equities and Potential Positions

Avanos Medical
AVNS
Specialization
Health Care, Health Care Equipment & Services
LocationGeorgia; U.S.A
ExchangeNew York Stock Exchange
USD 19.16

Additional Tools for Avanos Stock Analysis

When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.